TET1 and triple-negative breast carcinoma: In triple negative breast cancer (TNBC), EZH2 was shown to downregulate TET1 expression and consequently inhibited tumor senesence and apoptosis, indicating that TET1 is a tumor suppressor, also in TNBC (25).